Tom Valuck

Tom Valuck

Auto-generated profile, based on publicly available information

Tom Valuck

Real Chemistry , New York, NY

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2026 in Health Affairs Scholar
Verified
Journal Article
Open access
PDF file
ABAlan Balch
Alan Balch
MLMichael Lahm
Michael Lahm
KBKimberly Diane Brunisholz
Kimberly Diane Brunisholz
CMCourtney Morrow
Courtney Morrow
CBChristine Brittle
Christine Brittle
TVTom Valuck
Tom Valuck
Introduction: Patient perspectives and preferences are important when establishing quality and cost metrics for value-based payment (VBP) models, to ensure patient-centered cancer care and VBP incentives are aligned. Methods: Insights were gathered about value-based care (VBC) models from patients with Medicare and one of 4 common cancers (multiple myeloma, bladder, lung, and prostate) included in Medicare's Enhancing Oncology Model. This study included 4 virtual 2-hour focus groups and a 2-hour co-creation session. Aspects of cost and quality important to cancer care were identified (value is defined as the ratio of quality/cost). Results: Insights from the focus groups (n = 20) and co-creation session (n = 6) highlighted a lack of awareness about VBC and concerns about the effect of financial incentives on oncology care. Focus group participants identified shared decision-making and treatment effectiveness outcomes as the most important elements of quality. Co-creation participants highlighted a need for improved awareness about the implications of VBP incentives for oncology care decisions. Conclusion: In this exploratory qualitative research, patients with cancer expressed a need for transparency of VBC dynamics to help preserve the patient–physician relationship and their ability to receive innovative, affordable, and accessible care.